Science Explorer Back to mapMap
Discussion
Researcher · Novartis (Switzerland) · Switzerland

Andrea Kay

Andrea Kay publishes mostly in Pulmonary and Respiratory Medicine, Infectious Diseases and Oncology, on topics such as Renal cell carcinoma treatment, COVID-19 Clinical Research Studies and SARS-CoV-2 and COVID-19 Research.

OpenAlex
World rank
#78,972
of 7,710,434 ranked researchers
Rank in Switzerland
#1,670
of 80,918
Works
86
Citations
14k
Citations per work
163.6
h-index
36
i10-index 55Top 5.8% in Pulmonary and Respiratory Medicine
Andrea Kay

What does Andrea Kay research?

Andrea Kay's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (16%).

Health Sciences: 38 works · 43.8% of their workMedicine: 38 works · 43.8% of their workPulmonary and Respiratory Medicine: 13 works · 15.2% of their workInfectious Diseases: 10 works · 11.9% of their workOncology: 10 works · 11.9% of their workCardiology and Cardiovascular Medicine: 4 works · 4.8% of their workEverything else: 35 works · 40.4% of their workLife Sciences: 14 works · 15.8% of their workBiochemistry, Genetics and Molecular Biology: 14 works · 15.8% of their workMolecular Biology: 9 works · 11.0% of their workCancer Research: 4 works · 4.8% of their workTHEIR WORKAndrea Kay86works
Life Sciences16%Health Sciences44%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3843.8%
  2. Everything else3540.4%
    1. Biochemistry, Genetics and Molecular Biology1415.8%
  1. 1Pulmonary and Respiratory Medicine15% of their works
  2. 2Infectious Diseases12% of their works
  3. 3Oncology12% of their works
  4. 4Molecular Biology11% of their works
  5. 5Cardiology and Cardiovascular Medicine5% of their works
  6. 6Cancer Research5% of their works

Research topics

Which keywords describe Andrea Kay's research?

The keywords of their largest research topics: ACE2 Receptor, SARS-CoV-2, Therapy, Metastatic, Renal Cell Carcinoma, Targeted Therapy, Clinical Characteristics and Epidemiology.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. ACE2 Receptor252 topics
  2. SARS-CoV-2252 topics
  3. Therapy222 topics
  4. Metastatic171 topic
  5. Renal Cell Carcinoma171 topic
  6. Targeted Therapy162 topics
  7. Clinical Characteristics151 topic
  8. Epidemiology151 topic
  9. Coronavirus101 topic
  10. Vaccine101 topic
  11. ALK Inhibitors81 topic
  12. Cancer Genomics81 topic
  13. EGFR Mutations81 topic
  14. Mutational Signatures81 topic
  15. Cetuximab61 topic
  16. KRAS Mutations61 topic
  17. FGF2151 topic
  18. Fibroblast Growth Factor51 topic
  19. Neurologic Manifestations51 topic
  20. Post-acute COVID-19 Syndrome51 topic

Where does Andrea Kay work?

Andrea Kay's main affiliation in the publication record is Novartis (Switzerland), Switzerland.

How many publications and citations does Andrea Kay have?

OpenAlex counts 86 works and 14,073 citations for Andrea Kay, an h-index of 36, ranking #78,972 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Andrea Kay. Posts are plain text and can be reported.